Zdrowie i gospodarka · 02/04/2019

FDA Clears ONFI (Clobazam) Tablets for Approval

The FDA has ruled that the 5mg version of ONFI tablets, a medication by Novartis, was not removed from the market due to safety or efficacy concerns, paving the way for potential approval of generic versions.